<DOC>
	<DOCNO>NCT01847443</DOCNO>
	<brief_summary>The primary objective study compare pharmacokinetic ( PK ) profile assess bioequivalence newly develop nicotine gum ( 2 mg 4 mg ) reference nicotine gum ( 2 mg 4 mg ) healthy smoker .</brief_summary>
	<brief_title>Comparison Pharmacokinetic Profiles Two Nicotine Gum Formulations</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>BMI within range 19 30 kilograms/meters^2 Current cigarette smoker smoke daily least year , smoke first cigarette within 30 minute wake Participants attempt quit smoking last 12 month , currently attempt quit smoking reduce number cigarette smoke , intend quit smoke next 3 month , without use smoking cessation aid Treatment know hepatic enzyme alter agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>nicotine</keyword>
	<keyword>nicotine replacement therapy</keyword>
	<keyword>nicotine gum</keyword>
</DOC>